Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD

Chest

Volumn 151, Issue 1, 2017, Pages 68-77

  Lambert, Allison A ^a   Putcha, Nirupama ^a   Drummond, M Bradley ^a   Boriek, Aladin M ^b   Hanania, Nicola A ^b   Kim, Victor ^c   Kinney, Gregory L ^d   McDonald, Merry Lynn N ^e   Brigham, Emily P ^a   Wise, Robert A ^a   McCormack, Meredith C ^a   Hansel, Nadia N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Global Health and Health Disparities   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

COPD; dose response; exacerbation; morbidity; obesity

Indexed keywords

ADULT; AGED; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCORE; MORBIDITY; MULTICENTER STUDY; OBESITY; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; SHORT FORM 36; SIX MINUTE WALK TEST; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CLINICAL TRIAL; ENDURANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS; UNITED STATES;

AGED; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OBESITY; PHYSICAL ENDURANCE; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICS AS TOPIC; SYMPTOM FLARE UP; UNITED STATES;

EID: 85009792779     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.08.1432     Document Type: Conference Paper

References (65)

1. 1 Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults–United States, 2011. MMWR Morb Mortal Wkly Rep 61:46 (2012), 938–943.
2. 2 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation 131:4 (2015), e29–e322.
3. 3 Flegal, K.M., Carroll, M.D., Kit, B.K., Ogden, C.L., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:5 (2012), 491–497.
4. 4 Flegal, K.M., Carroll, M.D., Ogden, C.L., Curtin, L.R., Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:3 (2010), 235–241.
5. 5 Steuten, L.M., Creutzberg, E.C., Vrijhoef, H.J., Wouters, E.F., COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 15:2 (2006), 84–91.
6. 6 Eisner, M.D., Blanc, P.D., Sidney, S., et al. Body composition and functional limitation in COPD. Respir Res, 8, 2007, 7.
7. 7 Montes de Oca, M., Talamo, C., Perez-Padilla, R., et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. Respir Med 102:5 (2008), 642–650.
8. 8 O'Donnell, D.E., Deesomchok, A., Lam, Y.M., et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 140:2 (2011), 461–468.
9. 9 Vozoris, N.T., O'Donnell, D.E., Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 19:3 (2012), e18–e24.
10. 10 Wagner, P.D., Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31:3 (2008), 492–501.
11. 11 Lainscak, M., von Haehling, S., Doehner, W., et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2:2 (2011), 81–86.
12. 12 Schols, A.M., Slangen, J., Volovics, L., Wouters, E.F., Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:6 Pt 1 (1998), 1791–1797.
13. 13 Katsura, H., Yamada, K., Kida, K., Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 99:5 (2005), 624–630.
14. 14 Landbo, C., Prescott, E., Lange, P., Vestbo, J., Almdal, T.P., Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:6 (1999), 1856–1861.
15. 15 Kastorini, C.M., Panagiotakos, D.B., The obesity paradox: methodological considerations based on epidemiological and clinical evidence–new insights. Maturitas 72:3 (2012), 220–224.
16. 16 Prescott, E., Almdal, T., Mikkelsen, K.L., Tofteng, C.L., Vestbo, J., Lange, P., Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 20:3 (2002), 539–544.
17. 17 Rutten, E.P., Calverley, P.M., Casaburi, R., et al. Changes in body composition in patients with chronic obstructive pulmonary disease: Do they influence patient-related outcomes?. Ann Nutr Metab 63:3 (2013), 239–247.
18. 18 O'Donnell, D.E., Ciavaglia, C.E., Neder, J.A., When obesity and chronic obstructive pulmonary disease collide: physiological and clinical consequences. Ann Am Thorac Soc 11:4 (2014), 635–644.
19. 19 Koenig, S.M., Pulmonary complications of obesity. Am J Med Sci 321:4 (2001), 249–279.
20. 20 Franssen, F.M., O'Donnell, D.E., Goossens, G.H., Blaak, E.E., Schols, A.M., Obesity and the lung: 5. Obesity and COPD. Thorax 63:12 (2008), 1110–1117.
21. 21 McClean, K.M., Kee, F., Young, I.S., Elborn, J.S., Obesity and the lung: 1. Epidemiology. Thorax 63:7 (2008), 649–654.
22. 22 Katz, P., Iribarren, C., Sanchez, G., Blanc, P.D., Obesity and functioning among individuals with chronic obstructive pulmonary disease (COPD). COPD 13:3 (2016), 352–359.
23. 23 Divo, M.J., Cabrera, C., Casanova, C., et al. Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis 1:2 (2014), 229–238.
24. 24 Blum, A., Simsolo, C., Sirchan, R., Haiek, S., “Obesity paradox” in chronic obstructive pulmonary disease. Isr Med Assoc J 13:11 (2011), 672–675.
25. 25 Vestbo, J., Prescott, E., Almdal, T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173:1 (2006), 79–83.
26. 26 Cecere, L.M., Littman, A.J., Slatore, C.G., et al. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD 8:4 (2011), 275–284.
27. 27 Haldar, S., Chia, S.C., Henry, C.J., Body composition in Asians and Caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res 75 (2015), 97–154.
28. 28 Katz, D.A., McHorney, C.A., Atkinson, R.L., Impact of obesity on health-related quality of life in patients with chronic illness. J Gen Intern Med 15:11 (2000), 789–796.
29. 29 Mannino, D.M., Homa, D.M., Akinbami, L.J., Ford, E.S., Redd, S.C., Chronic obstructive pulmonary disease surveillance–United States, 1971-2000. MMWR Surveill Summ 51:6 (2002), 1–16.
30. 30 Regan, E.A., Hokanson, J.E., Murphy, J.R., et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7:1 (2010), 32–43.
31. 31 Martinez, C.H., Mannino, D.M., Divo, M.J., Defining COPD-related comorbidities, 2004-2014. Chronic Obstr Pulm Dis 1:1 (2014), 51–63.
32. 32 Putcha, N., Han, M.K., Martinez, C.H., et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis 1:1 (2014), 105–114.
33. 33 Putcha, N., Puhan, M.A., Drummond, M.B., et al. A simplified score to quantify comorbidity in COPD. PloS One, 9(12), 2014, e114438.
34. 34 Jones, P.W., Quirk, F.H., Baveystock, C.M., The St George's Respiratory Questionnaire. Respir Med 85:suppl B (1991), 25–31.
35. 35 Barr, J.T., Schumacher, G.E., Freeman, S., LeMoine, M., Bakst, A.W., Jones, P.W., American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 22:9 (2000), 1121–1145.
36. 36 Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:6 (1992), 473–483.
37. 37 McHorney, C.A., Ware, J.E. Jr., Raczek, A.E., The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:3 (1993), 247–263.
38. 38 Butland, R.J., Pang, J., Gross, E.R., Woodcock, A.A., Geddes, D.M., Two-, six-, and 12-minute walking tests in respiratory disease. BMJ 284:6329 (1982), 1607–1608.
39. 39 Solway, S., Brooks, D., Lacasse, Y., Thomas, S., A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 119:1 (2001), 256–270.
40. 40 Fletcher, C.M., The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med 45:9 (1952), 577–584.
41. 41 Bestall, J.C., Paul, E.A., Garrod, R., Garnham, R., Jones, P.W., Wedzicha, J.A., Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:7 (1999), 581–586.
42. 42 Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD – 2016. http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/. Accessed September 19, 2016.
43. 43 Celli, B.R., MacNee, W., Force, A.E., Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:6 (2004), 932–946.
44. 44 Han, M.K., Muellerova, H., Curran-Everett, D., et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 1:1 (2013), 43–50.
45. 45 World Health Organization. BMI classification. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Accessed May 5, 2015.
46. 46 Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158:17 (1998), 1855–1867.
47. 47 Checkley, W., Foreman, M.G., Bhatt, S.P., et al. Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease. Respir Med 111 (2016), 30–38.
48. 48 Wan, E.S., Castaldi, P.J., Cho, M.H., et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res, 15, 2014, 89.
49. 49 Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:13 (2006), 1549–1555.
50. 50 Garcia-Rio, F., Soriano, J.B., Miravitlles, M., et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PloS One, 9(8), 2014, e105220.
51. 51 Rodriguez, D.A., Garcia-Aymerich, J., Valera, J.L., et al. Determinants of exercise capacity in obese and non-obese COPD patients. Respir Med 108:5 (2014), 745–751.
52. 52 Launois, C., Barbe, C., Bertin, E., et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study. BMC Pulm Med, 12, 2012, 61.
53. 53 Jones, P.W., St. George's Respiratory Questionnaire: MCID. COPD 2:1 (2005), 75–79.
54. 54 Polkey, M.I., Spruit, M.A., Edwards, L.D., et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 187:4 (2013), 382–386.
55. 55 Morgan, O.W., Bramley, A., Fowlkes, A., et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PloS One, 5(3), 2010, e9694.
56. 56 Hauck, K., Hollingsworth, B., The impact of severe obesity on hospital length of stay. Med Care 48:4 (2010), 335–340.
57. 57 de Torres, J.P., Casanova, C., Hernandez, C., Abreu, J., Aguirre-Jaime, A., Celli, B.R., Gender and COPD in patients attending a pulmonary clinic. Chest 128:4 (2005), 2012–2016.
58. 58 Cote, C.G., Chapman, K.R., Diagnosis and treatment considerations for women with COPD. Int J Clin Pract 63:3 (2009), 486–493.
59. 59 Kanner, R.E., Connett, J.E., Altose, M.D., et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 150:4 (1994), 956–961.
60. 60 Di Marco, F., Verga, M., Reggente, M., et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 100:10 (2006), 1767–1774.
61. 61 Breyer, M.K., Rutten, E.P., Vernooy, J.H., et al. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 105:7 (2011), 1046–1053.
62. 62 Bastard, J.P., Maachi, M., Lagathu, C., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:1 (2006), 4–12.
63. 63 Sood, A., Obesity, adipokines, and lung disease. J Appl Physiol 108:3 (2010), 744–753.
64. 64 Broekhuizen, R., Vernooy, J.H., Schols, A.M., Dentener, M.A., Wouters, E.F., Leptin as local inflammatory marker in COPD. Respir Med 99:1 (2005), 70–74.
65. 65 Carroll, J.F., Chiapa, A.L., Rodriquez, M., et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 16:3 (2008), 600–607.